Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 15 results found. Search for [ Roche Holding ]

Results 1 to 15 of 15
BusinessToday.In
October 8, 2020
Donald Trump, who was admitted at Walter Reed National Military Medical centre on Friday, had received \"a single 8-gram dose\" of Regeneron's monoclonal antibody cocktail


Reuters
March 28, 2020
U.S. Food and Drug Administration granted the approval under its Emergency Use Authorization


BusinessToday.In
New Delhi, March 13, 2020
Coronavirus outbreak: The deceased 69-year-old woman contracted the deadly virus from her son, who has travel history to Switzerland and Italy


BusinessToday.In
New Delhi, March 4, 2020
Coronavirus update: A Paytm employee in Gurugram, who returned from Italy, has been tested positive for novel coronavirus, the company said in a statement on Wednesday


P.B. Jayakumar
Delhi, May 1, 2017
Unlike many of the India Inc. successors who had got smoothly running companies on a platter, Habil Khorakiwala's younger son Murtaza faced a tough beginning.


Zeba Siddiqui
Mumbai, November 7, 2014
The move comes after Ranbaxy Labs said on Thursday that FDA had stripped the company of its tentative approval to launch the first copy of the drug due to quality control issues at its plants.


Suprotip Ghosh
November 5, 2014
The trend we are seeing now politically will help our business, which has positively developed even under previous administrations.


Nita Bhalla
New Delhi, September 30, 2014
The country's patent law enables domestic firms to produce generic drugs poor people can afford, which undermines the interests of US pharmaceutical companies.


Chuck Mikolajczak
New York, August 26, 2014
The index has managed to climb despite cautious signals investors, including a reduction in stimulus from the Federal Reserve and a simmering conflict between Ukraine and Russia.


Manoj Kumar
May 1, 2014
Commerce Secretary Rajeev Kher praised a decision by the US Trade Representative not to label India with its worst offender tag in an annual scorecard on protecting U.S. patents, copyrights and other intellectual property.


Sumeet Chatterjee and Ben Hirschler
Mumbai/London, February 6, 2014
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent.


Reuters
London, May 2, 2013
Royal Dutch Shell's 54-year old chief executive Peter Voser is to retire next year in a surprise early departure that he said was driven by a desire for a change of lifestyle.


E. Kumar Sharma
April 1, 2013
The Supreme Court has dismissed the Swiss drugmaker's attempt to win patent protection for its cancer drug Glivec, a ruling that does not bode well for many big global pharma companies fighting intellectual property battles in India.


E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?


Nitya Varadarajan
April 14, 2010
With a near-death experience behind it, Orchid Chemicals prepares to fly again. K. Raghavendra Rao, MD, is as audacious as ever.


PAGES 1 OF 1